| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features (NCT01048892) | Children's Oncology Group | 2009-09-01 |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT00903396) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors (NCT00427349) | Eastern Cooperative Oncology Group | 2008-11-07 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors (NCT00454376) | National Cancer Institute (NCI) | 2006-10-01 |
| Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors (NCT00602082) | Cambridge University Hospitals NHS Foundation Trust | 2005-08-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors (NCT00227617) | University of California, San Francisco | 2005-06-08 |
| Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery (NCT00416767) | Federation Francophone de Cancerologie Digestive | 2004-05-01 |
| Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors (NCT00049023) | O'Dorisio, M S | 2002-01-01 |
| PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors (NCT00017199) | Ohio State University Comprehensive Cancer Center | 2001-04-01 |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors (NCT00027638) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (NCT00004910) | Northwestern University | 2000-01-01 |
| Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction (NCT00004911) | Northwestern University | 2000-01-01 |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer (NCT00019474) | Montefiore Medical Center | 1998-03-01 |
| Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer (NCT00006368) | Novartis Pharmaceuticals | 1998-01-01 |
| Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (NCT00005049) | NYU Langone Health | 1997-05-01 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (NCT00002947) | Yale University | 1996-10-01 |
| Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors (NCT00227773) | Eastern Cooperative Oncology Group | |